- Home
- BCLI vs IVDA Comparison
BCLI vs IVDA Comparison
Compare BCLI & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- IVDA
- Stock Information
- Founded
- BCLI 2000
- IVDA 2003
- Country
- BCLI United States
- IVDA United States
- Employees
- BCLI N/A
- IVDA N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- IVDA Computer Software: Prepackaged Software
- Sector
- BCLI Health Care
- IVDA Technology
- Exchange
- BCLI Nasdaq
- IVDA Nasdaq
- Market Cap
- BCLI 6.4M
- IVDA 7.0M
- IPO Year
- BCLI N/A
- IVDA N/A
- Fundamental
- Price
- BCLI $0.92
- IVDA $2.87
- Analyst Decision
- BCLI Strong Buy
- IVDA
- Analyst Count
- BCLI 1
- IVDA 0
- Target Price
- BCLI $30.00
- IVDA N/A
- AVG Volume (30 Days)
- BCLI 366.6K
- IVDA 34.7K
- Earning Date
- BCLI 05-13-2025
- IVDA 04-15-2025
- Dividend Yield
- BCLI N/A
- IVDA N/A
- EPS Growth
- BCLI N/A
- IVDA N/A
- EPS
- BCLI N/A
- IVDA N/A
- Revenue
- BCLI N/A
- IVDA $6,020,639.00
- Revenue This Year
- BCLI N/A
- IVDA $340.48
- Revenue Next Year
- BCLI N/A
- IVDA N/A
- P/E Ratio
- BCLI N/A
- IVDA N/A
- Revenue Growth
- BCLI N/A
- IVDA N/A
- 52 Week Low
- BCLI $0.72
- IVDA $1.27
- 52 Week High
- BCLI $10.05
- IVDA $8.05
- Technical
- Relative Strength Index (RSI)
- BCLI 35.85
- IVDA 57.55
- Support Level
- BCLI $1.12
- IVDA $2.40
- Resistance Level
- BCLI $0.82
- IVDA $2.79
- Average True Range (ATR)
- BCLI 0.12
- IVDA 0.32
- MACD
- BCLI 0.01
- IVDA 0.03
- Stochastic Oscillator
- BCLI 36.36
- IVDA 96.14
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).